ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 350629 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 350629; 2) Community: the network communities that were significantly associated with the response to NSC 350629; 3) Molecule: the relationships between components within communities and NSC 350629; 4) MDR: the compounds that were significantly associated with the NSC 350629.

NSC Compound Enrichment Correlation
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0105972823829604 0.229163
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0105972823829604 0.43036393
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0105972823829604 0.62124945
NSC 736802 Null 0.0105972823829604 0.34482256
NSC 743876 Null 0.0105972823829604 0.35755979
NSC 748715 Null 0.0105972823829604 0.30949014
NSC 759178 Pipamperone 0.0105972823829604 0.30876262
NSC 136037 AT 116, benzylamine salt 0.0119221520283057 0.13903664
NSC 139490 Emfolin sodium 0.0119221520283057 0.26591188
NSC 15372 4-Hydroxyphenyl-.beta.-naphthylamine 0.0119221520283057 0.035470148
Total:116  Current:47    [First] [Prev] [Next] [Last]